Suppr超能文献

胃复安和舒必利作为突触前和突触后多巴胺受体的选择性阻断剂。

Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.

作者信息

Alander T, Andén N E, Grabowska-Andén M

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):145-50. doi: 10.1007/BF00569723.

Abstract
  1. The effects of sulpiride and metoclopramide on pre- and postsynaptic dopamine receptors were investigated in the rat brain as antagonism of the apomorphine-induced inhibition of the dopamine synthesis in the absence of nerve impulses and as blockade of the apomorphine-induced rotation following unilateral inactivation of the corpus striatum, respectively. Sulpiride was more potent in blocking post- than presynaptic dopamine receptors whereas the reverse was found for metoclopramide. 2. The synthesis and the utilization of dopamine was stimulated by sulpiride and metoclopramide and was inhibited by atropine, prazosin and aminooxyacetic acid. The inhibitory effects of the latter three drugs were counteracted by metoclopramide, but not by sulpiride. This difference can be explained by the preferential action of metoclopramide on presynaptic dopamine receptors. 3. Following unilateral inactivation of the corpus striatum, metoclopramide at a low dose, but not sulpiride turned the rats ipsilaterally, indicating that the release of dopamine was facilitated and that the presynaptic dopamine receptors are of physiological significance.
摘要
  1. 分别在大鼠脑中研究了舒必利和甲氧氯普胺对突触前和突触后多巴胺受体的作用,前者表现为在无神经冲动时对阿扑吗啡诱导的多巴胺合成抑制的拮抗作用,后者表现为单侧纹状体失活后对阿扑吗啡诱导的旋转行为的阻断作用。舒必利对突触后多巴胺受体的阻断作用强于突触前,而甲氧氯普胺的情况则相反。2. 舒必利和甲氧氯普胺刺激多巴胺的合成和利用,而阿托品、哌唑嗪和氨氧乙酸则抑制其合成和利用。后三种药物的抑制作用可被甲氧氯普胺抵消,但不能被舒必利抵消。这种差异可以通过甲氧氯普胺对突触前多巴胺受体的优先作用来解释。3. 单侧纹状体失活后,低剂量的甲氧氯普胺可使大鼠向同侧旋转,而舒必利则无此作用,这表明多巴胺的释放得到促进,且突触前多巴胺受体具有生理意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验